CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-09-26 | Glazer Donald W. Director | Sale | −20,666 | $29.58 | $611K | 67,946 |
| 2016-09-23 | Glazer Donald W. Director | Sale | −11,433 | $30.77 | $352K | 88,612 |
| 2016-09-22 | Glazer Donald W. Director | Sale | −25,010 | $31.13 | $779K | 100,045 |
| 2016-09-21 | Glazer Donald W. Director | Sale | −16,318 | $31.19 | $509K | 125,055 |
| 2016-09-20 | Glazer Donald W. Director | Sale | −8,243 | $31.01 | $256K | 141,373 |
| 2016-09-19 | Glazer Donald W. Director | Sale | −40,791 | $31.56 | $1.3M | 151,516 |
| 2016-09-19 | Glazer Donald W. Director | Sale | −1,900 | $32.17 | $61K | 149,616 |
| 2016-09-02 | Huang Jane CMO, Hematology | Grant or award | +300,000 | 300,000 | ||
| 2016-09-02 | Huang Jane CMO, Hematology | Grant or award · Share Option (Right to Buy) | +1,400,000 | 1,400,000 | ||
| 2016-08-22 | Peterson Amy C. CMO, Immuno-oncology | Grant or award | +300,000 | 300,000 | ||
| 2016-08-22 | Peterson Amy C. CMO, Immuno-oncology | Grant or award · Share Option (Right to Buy) | +1,600,000 | 1,600,000 | ||
| 2016-07-14 | Glazer Donald W. Director | Gift | −3 | 4,881,997 | ||
| 2016-07-13 | Yang Jianxin Sr. VP, Head of Clinical Dev. | Grant or award · Share Option (Right to Buy) | +825,000 | 825,000 | ||
| 2016-07-13 | Li Ji EVP and Gl. Head of Bus. Dev. | Grant or award · Share Option (Right to Buy) | +260,000 | 260,000 | ||
| 2016-07-13 | Yan Wendy Xiaojun Sr. VP, Head of Reg. Affairs | Grant or award · Share Option (Right to Buy) | +825,000 | 825,000 | ||
| 2016-07-07 | Glazer Donald W. Director | Gift | −250,000 | 4,882,000 | ||
| 2016-05-03 | Li Ji EVP and Gl. Head of Bus. Dev. | Grant or award | +475,000 | 475,000 | ||
| 2016-05-03 | Li Ji EVP and Gl. Head of Bus. Dev. | Grant or award · Share Option (Right to Buy) | +2,376,000 | 2,376,000 | ||
| 2016-02-08 | Merck & Co., Inc. 10% owner | Conversion | +18,518,519 | 18,518,519 | ||
| 2016-02-08 | Merck & Co., Inc. 10% owner | Conversion | +5,128,205 | 5,128,205 |
Page 121 of 123 · 2,455 trades